378 filings
Page 3 of 19
6-K
BNTX
BioNTech SE
7 Aug 23
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
6:06am
6-K
BNTX
BioNTech SE
31 Jul 23
BioNTech Completes Acquisition of InstaDeep
8:12am
144
Jeggle Helmut Wolfgang
29 Jun 23
Notice of proposed sale of securities
4:52pm
6-K
BNTX
BioNTech SE
29 Jun 23
Current report (foreign)
7:09am
144
Athos KG
28 Jun 23
Notice of proposed sale of securities
5:20pm
6-K
BNTX
BioNTech SE
26 Jun 23
Current report (foreign)
5:26pm
6-K
BNTX
BioNTech SE
23 Jun 23
Current report (foreign)
4:41pm
6-K
BNTX
BioNTech SE
2 Jun 23
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
8:51am
6-K
BNTX
BioNTech SE
2 Jun 23
Current report (foreign)
8:48am
6-K
BNTX
BioNTech SE
26 May 23
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission
7:43am
6-K
BNTX
BioNTech SE
25 May 23
Changes in the Supervisory Board of BioNTech SE and Voting Results from the Annual General Meeting 2023
4:06pm
6-K
BNTX
BioNTech SE
8 May 23
Current report (foreign)
9:22am
6-K
BNTX
BioNTech SE
8 May 23
Current report (foreign)
6:56am
6-K
BNTX
BioNTech SE
8 May 23
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
6:53am
6-K
BNTX
BioNTech SE
13 Apr 23
Invitation to the Annual General Meeting 2023
4:25pm
6-K
BNTX
BioNTech SE
3 Apr 23
Current report (foreign)
8:07am
6-K
BNTX
BioNTech SE
28 Mar 23
BioNTech Announces New ADS Repurchase Program
6:59am
20-F
2022 FY
BNTX
BioNTech SE
Annual report (foreign)
27 Mar 23
7:00am
6-K
BNTX
BioNTech SE
27 Mar 23
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
6:49am
6-K
BNTX
BioNTech SE
20 Mar 23
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications
8:00am